Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
about
A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment.Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment.Application of physiologically based pharmacokinetic models in chemical risk assessment.A physiologically based pharmacokinetic model for the broad-spectrum antimicrobial zinc pyrithione: I. Development and verification.
P2860
Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Investigation of the potential ...... in noncancer risk assessment.
@en
type
label
Investigation of the potential ...... in noncancer risk assessment.
@en
prefLabel
Investigation of the potential ...... in noncancer risk assessment.
@en
P2093
P2860
P1476
Investigation of the potential ...... in noncancer risk assessment.
@en
P2093
Clewell HJ 3rd
Gearhart JM
P2860
P304
P356
10.1080/00984109708984077
P577
1997-12-01T00:00:00Z